{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:38:01Z","timestamp":1780472281101,"version":"3.54.1"},"reference-count":43,"publisher":"American Academy of Pediatrics (AAP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1542\/pir.2016-0234","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T08:30:35Z","timestamp":1509525035000},"page":"511-519","source":"Crossref","is-referenced-by-count":12,"title":["Hand and Foot Color Change: Diagnosis and Management"],"prefix":"10.1542","volume":"38","author":[{"given":"Dustin E.","family":"Fleck","sequence":"first","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Hoeltzel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"2021121011513059100_B1","first-page":"101","article-title":"Clinical aspects of acrocyanosis","volume":"10","author":"Davis","year":"1982","journal-title":"Adv Microcirc."},{"issue":"15","key":"2021121011513059100_B2","first-page":"1641","article-title":"Definition and epidemiology of vascular acrosyndromes","volume":"48","author":"Carpentier","year":"1998","journal-title":"Rev Prat"},{"key":"2021121011513059100_B3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-8703(36)90230-2","article-title":"Acrocyanosis: a study of the circulatory fault","volume":"11","author":"Elliot","year":"1936","journal-title":"Am Heart J"},{"key":"2021121011513059100_B4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2133.1937.tb11164.x","article-title":"The aetiology and pathology of acrocyanosis","volume":"49","author":"Stern","year":"1937","journal-title":"Br J Dermatol"},{"issue":"2","key":"2021121011513059100_B5","first-page":"171","article-title":"Paradoxical aspects of acrocyanosis and its pathogenesis","volume":"8","author":"Merlen","year":"1983","journal-title":"J Mal Vasc"},{"issue":"2","key":"2021121011513059100_B6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2310\/7750.2014.14052","article-title":"Diseases of abnormal sensitivity to cold in children on psychostimulant drugs","volume":"19","author":"Coulombe","year":"2015","journal-title":"J Cutan Med Surg"},{"issue":"783","key":"2021121011513059100_B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/pgmj.67.783.33","article-title":"Acrocyanosis in anorexia nervosa","volume":"67","author":"Bhanji","year":"1991","journal-title":"Postgrad Med J"},{"issue":"2","key":"2021121011513059100_B8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1525-1470.1999.00022.x","article-title":"Dermatologic findings in anorexia and bulimia nervosa of childhood and adolescence","volume":"16","author":"Schulze","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"16","key":"2021121011513059100_B9","first-page":"565","article-title":"Cutaneous manifestations in anorexia nervosa","volume":"130","author":"Hediger","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"issue":"1","key":"2021121011513059100_B10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mjd.2002.120474","article-title":"Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae","volume":"47","author":"Poszepczynska-Guign\u00e9","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2021121011513059100_B11","doi-asserted-by":"crossref","first-page":"H2161","DOI":"10.1152\/ajpheart.00600.2007","article-title":"Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome","volume":"293","author":"Stewart","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2021121011513059100_B12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ptj\/70.1.45","article-title":"Acrocyanosis in a spinal cord injured patient\u2014effects of computer-controlled neuromuscular electrical stimulation: a case report","volume":"70","author":"Twist","year":"1990","journal-title":"Phys Ther"},{"issue":"2","key":"2021121011513059100_B13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1542\/peds.103.2.428","article-title":"Hair and skin disorders as signs of mitochondrial disease","volume":"103","author":"Bodemer","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"2021121011513059100_B14","first-page":"285","article-title":"Twisted collagen fibrils in acrocyanosis","volume":"9","author":"Kobayasi","year":"1999","journal-title":"Eur J Dermatol"},{"issue":"11","key":"2021121011513059100_B15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1966.tb12152.x","article-title":"The small blood vessels of the skin in acrocyanosis. Comparison of biomicroscopy and biopsy findings","volume":"78","author":"Sagher","year":"1966","journal-title":"Br J Dermatol"},{"issue":"1","key":"2021121011513059100_B16","doi-asserted-by":"crossref","first-page":"e55212","DOI":"10.1371\/journal.pone.0055212","article-title":"A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"2021121011513059100_B17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.CIR.29.1.136","article-title":"Erythermalgia: review of 51 cases","volume":"29","author":"Babb","year":"1964","journal-title":"Circulation"},{"issue":"3","key":"2021121011513059100_B18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaad.2011.01.010","article-title":"Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period","volume":"66","author":"Cook-Norris","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2021121011513059100_B19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archderm.136.3.330","article-title":"Natural history of erythromelalgia: presentation and outcome in 168 patients","volume":"136","author":"Davis","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"2021121011513059100_B20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2006.04.067","article-title":"Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density","volume":"55","author":"Davis","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2021121011513059100_B21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/320107","article-title":"The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32","volume":"68","author":"Drenth","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"Pt 3","key":"2021121011513059100_B22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/brain\/awg060","article-title":"Pathological C-fibres in patients with a chronic painful condition","volume":"126","author":"\u00d8rstavik","year":"2003","journal-title":"Brain"},{"issue":"4","key":"2021121011513059100_B23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1523-1747.2002.01726.x","article-title":"Impaired neurogenic control of skin perfusion in erythromelalgia","volume":"118","author":"M\u00f8rk","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2021121011513059100_B24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/archinte.1989.00390010109013","article-title":"Erythromelalgia and myeloproliferative disorders","volume":"149","author":"Kurzrock","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"2021121011513059100_B25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3344\/kjp.2013.26.3.299","article-title":"Secondary erythromelalgia\u2014a case report -","volume":"26","author":"Kang","year":"2013","journal-title":"Korean J Pain"},{"issue":"4","key":"2021121011513059100_B26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.1984.tb02379.x","article-title":"Histopathology of erythromelalgia in thrombocythaemia","volume":"8","author":"Michiels","year":"1984","journal-title":"Histopathology"},{"key":"2021121011513059100_B27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2021121011513059100_B28","first-page":"1320","article-title":"Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients","volume":"141","author":"Davis","year":"2005","journal-title":"Arch Dermatol"},{"issue":"4","key":"2021121011513059100_B29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0256-4947.55316","article-title":"Experience with oral mexiletine in primary erythromelalgia in children","volume":"29","author":"Iqbal","year":"2009","journal-title":"Ann Saudi Med"},{"key":"2021121011513059100_B30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1752-1947-3-106","article-title":"Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature","volume":"3","author":"Gaur","year":"2009","journal-title":"J Med Case Reports"},{"issue":"4 Pt 1","key":"2021121011513059100_B31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.111.4.715","article-title":"Raynaud\u2019s phenomenon in children: a retrospective review of 123 patients","volume":"111","author":"Nigrovic","year":"2003","journal-title":"Pediatrics"},{"issue":"12","key":"2021121011513059100_B32","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/art.11340","article-title":"Occurrence of Raynaud\u2019s phenomenon in children ages 12-15 years: prevalence and association with other common symptoms","volume":"48","author":"Jones","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2021121011513059100_B33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rdc.2004.10.005","article-title":"Estrogens and neuropeptides in Raynaud\u2019s phenomenon","volume":"31","author":"Generini","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"2021121011513059100_B34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","article-title":"Raynaud\u2019s phenomenon: from molecular pathogenesis to therapy","volume":"13","author":"Prete","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021121011513059100_B35","doi-asserted-by":"crossref","first-page":"iii33","DOI":"10.1093\/rheumatology\/kel280","article-title":"Pathophysiology and clinical consequences of Raynaud\u2019s phenomenon related to systemic sclerosis","volume":"45","author":"Sunderk\u00f6tter","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2021121011513059100_B36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0190-9622(80)80396-3","article-title":"Capillary alterations in scleroderma","volume":"2","author":"Fleischmajer","year":"1980","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2021121011513059100_B37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1525-1470.2006.00278.x","article-title":"The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients","volume":"23","author":"Pavlov-Dolijanovi\u0107","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"2021121011513059100_B38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/adc.77.4.299","article-title":"Usefulness of antinuclear antibody testing to screen for rheumatic diseases","volume":"77","author":"Malleson","year":"1997","journal-title":"Arch Dis Child"},{"key":"2021121011513059100_B39","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2021121011513059100_B40","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0196-9781(02)00265-6","article-title":"Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice","volume":"23","author":"Bangale","year":"2002","journal-title":"Peptides"},{"key":"2021121011513059100_B41","first-page":"CD002069","article-title":"Calcium channel blockers for primary Raynaud\u2019s phenomenon","volume":"2","author":"Ennis","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021121011513059100_B42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"2021121011513059100_B43","first-page":"1830","article-title":"Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud\u2019s phenomenon and systemic sclerosis: a randomized, open, single-center study","volume":"35","author":"Kawald","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/38\/11\/511\/825430\/pedsinreview_20160234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/38\/11\/511\/825430\/pedsinreview_20160234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T14:44:52Z","timestamp":1640097892000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/38\/11\/511\/34984\/Hand-and-Foot-Color-Change-Diagnosis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.2016-0234","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}